🇺🇸 intravenous hydromorphone and dexmedetomidine in United States

intravenous hydromorphone and dexmedetomidine (intravenous hydromorphone and dexmedetomidine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

intravenous hydromorphone and dexmedetomidine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is intravenous hydromorphone and dexmedetomidine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for intravenous hydromorphone and dexmedetomidine in United States?

Jun Wang is the originator. The local marketing authorisation holder may differ — check the official source linked above.